This work is licensed under the Creative Commons Attribution 4.0 International License.
Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg. 1996;15(4):250–7. doi: 10.1016/s1085-5629(96)80038-1.BocquetHBagotMRoujeauJCDrug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS)Semin Cutan Med Surg1996154250710.1016/s1085-5629(96)80038-1Open DOISearch in Google Scholar
Callot V, Roujeau JC, Bagot M, Wechsler J, Chosidow O, Souteyrand P, et al. Drug-induced pseudolymphoma and hypersensitivity syndrome. Two diferent clinical entities. Arch Dermatol. 1996;132(11):1315–21. doi: 10.1001/archderm.1996.03890350057010.CallotVRoujeauJCBagotMWechslerJChosidowOSouteyrandPet alDrug-induced pseudolymphoma and hypersensitivity syndrome. Two diferent clinical entitiesArch Dermatol19961321113152110.1001/archderm.1996.03890350057010Open DOISearch in Google Scholar
Choudhary S, McLeod M, Torchia D, Romanelli P. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. J Clin Aesthet Dermatol. 2013;6(6):31–7.ChoudharySMcLeodMTorchiaDRomanelliPDrug reaction with eosinophilia and systemic symptoms (DRESS) syndromeJ Clin Aesthet Dermatol201366317Search in Google Scholar
Tennis P, Stern RS. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study. Neurology. 1997;49(2):542–6. doi: 10.1212/wnl.49.2.542.TennisPSternRSRisk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage studyNeurology1997492542610.1212/wnl.49.2.5429270593Open DOISearch in Google Scholar
Metterle L, Hatch L, Seminario-Vidal L. Pediatric drug reaction with eosinophilia and systemic symptoms: a systematic review of the literature. Pediatr Dermatol. 2020;37(1):124–9. doi: 10.1111/pde.14044.MetterleLHatchLSeminario-VidalLPediatric drug reaction with eosinophilia and systemic symptoms: a systematic review of the literaturePediatr Dermatol2020371124910.1111/pde.1404431691347Open DOISearch in Google Scholar
Roquin G, Peres M, Lerolle N, Dib N, Mercat A, Croue A, et al. First report of lamotrigine-induced drug rash with eosinophilia and systemic symptoms syndrome with pancreatitis. Ann Pharmacother. 2010;44(12):1998–2000. doi: 10.1345/aph.1P350.RoquinGPeresMLerolleNDibNMercatACroueAet alFirst report of lamotrigine-induced drug rash with eosinophilia and systemic symptoms syndrome with pancreatitisAnn Pharmacother201044121998200010.1345/aph.1P35021098750Open DOISearch in Google Scholar
Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, et al. Variability in the clinical pattern of cutaneous side-efects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2007;156(3):609–11. doi: 10.1111/j.1365-2133.2006.07704.x. Comment on: Peyrière H, Dereure O, Breton H, Demoly P, Cociglio M, Blayac JP, Hillaire-Buys D; Network of the French Pharmacovigilance Centers. Variability in the clinical pattern of cutaneous side-efects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2006;155(2):422–8. doi: 10.1111/j.1365-2133.2006.07284.x.KardaunSHSidoroffAValeyrie-AllanoreLHalevySDavidoviciBBMockenhauptMet alVariability in the clinical pattern of cutaneous side-efects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol200715636091110.1111/j.1365-2133.2006.07704.xComment on: Peyrière H, Dereure O, Breton H, Demoly P, Cociglio M, Blayac JP, Hillaire-Buys D; Network of the French Pharmacovigilance Centers. Variability in the clinical pattern of cutaneous side-efects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2006;155(2):422–8. 10.1111/j.1365-2133.2006.07284.x17300272Open DOISearch in Google Scholar
Chaiken BH, Goldberg BI, Segal JP. Dilantin sensitivity; report of a case of hepatitis with jaundice, pyrexia and exfoliative dermatitis. N Engl J Med. 1950;242(23):897–8. doi: 10.1056/NEJM195006082422304.ChaikenBHGoldbergBISegalJPDilantin sensitivity; report of a case of hepatitis with jaundice, pyrexia and exfoliative dermatitisN Engl J Med195024223897810.1056/NEJM19500608242230415416921Open DOISearch in Google Scholar
Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest. 1988;82(6):1826– 32. doi: 10.1172/JCI113798.ShearNHSpielbergSPAnticonvulsant hypersensitivity syndrome. In vitro assessment of riskJ Clin Invest19888261826– 3210.1172/JCI1137984427603198757Open DOISearch in Google Scholar
Criado PR, Criado RF, Avancini JM, Santi CG. Drug reaction with Eosinophilia and Systemic Symptoms (DRESS)/Drug-induced Hypersensitivity Syndrome (DIHS): a review of current concepts. An Bras Dermatol. 2012;87(3):435–49. doi: 10.1590/s0365-05962012000300013.CriadoPRCriadoRFAvanciniJMSantiCGDrug reaction with Eosinophilia and Systemic Symptoms (DRESS)/Drug-induced Hypersensitivity Syndrome (DIHS): a review of current conceptsAn Bras Dermatol20128734354910.1590/s0365-0596201200030001322714760Open DOISearch in Google Scholar